Meningiomas are tumours that arise from the meninges, the protective membranes covering the brain and spinal cord. They are typically slow-growing and most often benign (non-cancerous), although some can be malignant. Meningiomas can occur in various locations, and their size and location can affect their symptoms and treatment options.
Common symptoms of meningiomas may include:
Diagnosis begins with medical history evaluation and a physical examination, to assess symptoms and neurological function. Imaging studies such as MRI is the preferred method to visualise the tumour’s presence, size and location. CT scans may also be used. In some cases, a biopsy may be performed to determine the tumours type and whether it is benign or malignant.
Small, asymptomatic meningiomas may be monitored with regular imaging studies without immediate intervention. The primary treatment for symptomatic or larger meningiomas, is surgery, where the goal is to remove as much of the tumour as possible, while minimising damage to surrounding tissues. Radiation therapy may be used after surgery (adjuvant therapy), or as a primary treatment for tumours that are unable to be surgically removed. Stereotactic radiosurgery is a focused radiation treatment option that targets the tumour precisely. The management of meningiomas is highly individualised, based on factors such as tumour size, location, patient health and symptoms. Ongoing follow-up with healthcare professionals specialising in neurosurgery and oncology is important for managing treatment and monitoring reoccurrence
Care of the Critically Ill Surgical Patient (CCrISP) is a two-day, interactive course, which includes mandatory, pre-course e-learning. It covers the practical skills and knowledge that health care professionals need to effectively care for surgical patients, including those who are deteriorating or at risk of doing so.